Found: 90
Select item for more details and to access through your institution.
Calcitonin Gene-Related Peptide Monoclonal Antibodies: Key Lessons from Real-World Evidence.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 9, p. 948, doi. 10.3390/brainsci14090948
- By:
- Publication type:
- Article
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01561-w
- By:
- Publication type:
- Article
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01521-w
- By:
- Publication type:
- Article
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1143, doi. 10.1111/head.14400
- By:
- Publication type:
- Article
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1351, doi. 10.1111/head.14194
- By:
- Publication type:
- Article
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 6, p. 936, doi. 10.1111/head.14123
- By:
- Publication type:
- Article
Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 2, p. 363, doi. 10.1111/head.14032
- By:
- Publication type:
- Article
Migraine as a Cortical Brain Disorder.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 9, p. 2103, doi. 10.1111/head.13935
- By:
- Publication type:
- Article
HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work‐Related Disability in Patients With Migraine?
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 2, p. 497, doi. 10.1111/head.13735
- By:
- Publication type:
- Article
Trigeminal‐Targeted Treatments in Migraine: Is 60% the Magic Number?
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 9, p. 1659, doi. 10.1111/head.13635
- By:
- Publication type:
- Article
Pharmacological Trials in Migraine: It's Time to Reappraise Where the Headache Is and What the Pain Is Like.
- Published in:
- 2015
- By:
- Publication type:
- Other
Prion Protein Gene M129V Polymorphism and Variability in Age at Migraine Onset.
- Published in:
- Headache: The Journal of Head & Face Pain, 2013, v. 53, n. 3, p. 540, doi. 10.1111/head.12043
- By:
- Publication type:
- Article
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2012, v. 52, n. 8, p. 1254, doi. 10.1111/j.1526-4610.2012.02154.x
- By:
- Publication type:
- Article
Botulinum Neurotoxin for the Treatment of Neuropathic Pain.
- Published in:
- Frontiers in Neurology, 2020, p. N.PAG, doi. 10.3389/fneur.2020.00716
- By:
- Publication type:
- Article
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 7, p. 672, doi. 10.3390/brainsci14070672
- By:
- Publication type:
- Article
Intracranial Venous Sinus Stenting in Idiopathic Intracranial Hypertension: A Case Report and Review of the Literature.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 3, p. 382, doi. 10.3390/brainsci11030382
- By:
- Publication type:
- Article
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.774341
- By:
- Publication type:
- Article
Current and emerging evidence-based treatment options in chronic migraine: a narrative review.
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s10194-019-1038-4
- By:
- Publication type:
- Article
Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-018-0948-x
- By:
- Publication type:
- Article
Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0949-9
- By:
- Publication type:
- Article
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, p. 1, doi. 10.1186/s10194-018-0928-1
- By:
- Publication type:
- Article
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0929-0
- By:
- Publication type:
- Article
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study.
- Published in:
- Journal of Headache & Pain, 2016, v. 17, n. 1, p. 1, doi. 10.1186/s10194-016-0684-z
- By:
- Publication type:
- Article
Correction: The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- Pain & Therapy, 2024, v. 13, n. 3, p. 319, doi. 10.1007/s40122-024-00581-x
- By:
- Publication type:
- Article
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 3, p. 611, doi. 10.1007/s40120-024-00591-z
- By:
- Publication type:
- Article
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 573, doi. 10.1177/0333102410388435
- By:
- Publication type:
- Article
No association between essential tremor and migraine: A case-control study.
- Published in:
- Cephalalgia, 2010, v. 30, n. 6, p. 686, doi. 10.1177/0333102409352253
- By:
- Publication type:
- Article
Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations.
- Published in:
- Nutrients, 2021, v. 13, n. 7, p. 2307, doi. 10.3390/nu13072307
- By:
- Publication type:
- Article
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 4, p. 1089, doi. 10.1111/ene.15670
- By:
- Publication type:
- Article
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 224, doi. 10.1111/ene.15563
- By:
- Publication type:
- Article
The first interim analysis of Italian patients enrolled in the real-world, Pan-European, prospective, observational, phase 4 PEARL study of fremanezumab effectiveness.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 5, p. 2353, doi. 10.1007/s10072-024-07357-3
- By:
- Publication type:
- Article
The first report of the Italian Migraine Registry (I-GRAINE).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Erenumab during pregnancy: a case report in a patient with chronic migraine.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study).
- Published in:
- Neurological Sciences, 2020, v. 41, p. 487, doi. 10.1007/s10072-020-04669-y
- By:
- Publication type:
- Article
Migraineurs' psychological traits do not influence response to erenumab.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 467, doi. 10.1007/s10072-020-04661-6
- By:
- Publication type:
- Article
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 12, p. 3385, doi. 10.1007/s10072-020-04767-x
- By:
- Publication type:
- Article
Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Erenumab: from scientific evidence to clinical practice-the first Italian real-life data.
- Published in:
- 2019
- By:
- Publication type:
- letter
Does the migraine attack start in the cortex and is the cortex critical in the migraine process?
- Published in:
- 2019
- By:
- Publication type:
- journal article
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Establishment of an Italian chronic migraine database: a multicenter pilot study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ketogenic diet in migraine: rationale, findings and perspectives.
- Published in:
- Neurological Sciences, 2017, v. 38, p. 111, doi. 10.1007/s10072-017-2889-6
- By:
- Publication type:
- Article
The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
- Published in:
- Neurological Sciences, 2017, v. 38, p. 31, doi. 10.1007/s10072-017-2907-8
- By:
- Publication type:
- Article
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study.
- Published in:
- Neurological Sciences, 2017, v. 38, p. 197, doi. 10.1007/s10072-017-2942-5
- By:
- Publication type:
- Article
Ketogenic diet in migraine: rationale, findings and perspectives.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study.
- Published in:
- 2017
- By:
- Publication type:
- journal article